Plain-English translation of NCT07602192 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking for better ways to tell asthma and COPD apart using detailed chest imaging scans and blood samples. Right now, these two lung diseases can be hard to distinguish, even though they need different treatments. By studying these imaging and biological markers together, researchers hope to develop personalized treatment plans that work better for each patient.
Many patients with asthma or COPD are not getting the right diagnosis or the right treatment because these diseases look similar. This study aims to find clear biological and imaging signatures that can help doctors accurately diagnose each disease and predict which patients will respond well to standard treatments.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital for baseline testing and follow-up appointments. At these visits, you'll complete breathing tests, answer questions about your symptoms, have your chest scanned with a CT machine, and provide blood samples—and possibly sputum or other samples if clinically appropriate. All of these are routine tests that reflect standard asthma and COPD care; no experimental drugs or devices are involved.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
South Korea